Takayuki Inoue

This inventor holds 14 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1993-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takayuki Inoue. Retrieved from https://idiyas.com/inventor/takayuki-inoue-aud6l0rk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14

% Patents Active = 85.7

Average Co-Inventor Count = 6.4

ph-index = 10

Forward Citations = 246(Granted Patents)

Company Filing History:

14 out of 940

Fujisawa Pharmaceutical Company, Ltd.

patents

Years Active: 1993-2003

Loading Chart...

Areas of Expertise:

Phosphodiesterase Inhibitors

Bradykinin Antagonists

Nitric Oxide Inhibitors

Imidazopyridinone Derivatives

Anthranilic Acid Derivatives

Quinoline Derivatives

Benzimidazole Compounds

Indolyl Carboxamides

Heterocyclic Compounds

Angiotensin II Antagonists

Peptide Compounds

Fused N-Heterocycles

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6582351 - Imidazopyridinone derivatives and their use as phosphodiesterase inhibitors (2003-06-24),

2. 6384080 - Anthranilic acid derivatives as inhibitors of the cGMP-phosphodiesterase (2002-05-07),

3. 6194396 - Benzimidazole compounds as bradykinin antagonists (2001-02-27),

4. 6169095 - Bradykinin antagonist quinolines (2001-01-02),

5. 6083961 - Benzimidazole compounds as bradykinin antagonists (2000-07-04),

6. 6083959 - Quinoline derivatives, processes for their preparation and their use as (2000-07-04),

7. 6069162 - Indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide (2000-05-30),

8. 5994368 - Pyridopyrimidones, quinolines and fused N-heterocycles as bradykinin (1999-11-30),

9. 5932737 - Peptide compounds for treatment of no-mediated diseases (1999-08-03),

10. 5922711 - 8-substituted quinazolines, quinoxalines and benzopyridazines (1999-07-13),

11. 5708173 - Heterocyclic compounds (1998-01-13),

12. 5563162 - Bradykinin antagonist quinolines (1996-10-08),

13. 5354759 - Angiotenin II antagonizing heterocyclic compounds (1994-10-11),

14. 5210092 - Angiotensin II antagonizing heterocyclic derivatives (1993-05-11),

Title: The Innovative Genius of Takayuki Inoue

Introduction: Takayuki Inoue, an esteemed inventor based in Tsukuba, Japan, has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of 14 patents, Inoue's work has been vital in advancing medical research and therapeutic applications.

Latest Patents: Among his latest innovations, Inoue has developed Imidazopyridinone derivatives and their use as phosphodiesterase inhibitors, alongside Anthranilic acid derivatives as inhibitors of the cGMP-phosphodiesterase. These patents reflect his dedication to enhancing drug efficacy and addressing critical health issues.

Career Highlights: Inoue is currently affiliated with Fujisawa Pharmaceutical Company, Ltd., where he has honed his skills and expertise in pharmaceutical research and development. His relentless pursuit of innovation has earned him a reputable position in the industry.

Collaborations: Throughout his career, Takayuki Inoue has collaborated with notable professionals, including Teruo Kyoto Oku and Yuki Sawada. These partnerships have fostered a creative environment that has led to groundbreaking discoveries in pharmacology.

Conclusion: Takayuki Inoue's contributions to the world of pharmaceuticals are both numerous and impactful. His innovative spirit continues to inspire his colleagues and advance the frontiers of medical science through his patents and collaborative efforts.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]